Kraspharma

Krasfarma PJSC is a Russian pharmaceutical company engaged in the production of antibiotics (based on imported substances) and the packaging of medicines.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Kraspharma balance sheet

Report period2020 2021 2022 2023 2024 Q2 25
End date of the reporting period
Capitalization, ₽
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Kraspharma cash flows

Report period2020 2021 2022 2023 2024 Q2 25 TTM
End date of the reporting period
Sales
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Kraspharma multipliers

Report period2020 2021 2022 2023 2024 Q2 25 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Kraspharma profitability

Report period2020 2021 2022 2023 2024 Q2 25 TTM
ROA
ROE
ROS
EBITDA Margin
Operating margin
Kraspharma assets
Kraspharma cash flows

Kraspharma dividend policy

The company does not pay dividends

Kraspharma shares

TickerNameTypeNominal valueISINPrice
KFAR:RMKraspharmaCommon shareRUB 50RU0007940912-
Share capital structure of Kraspharma
Kraspharma news
26.03.2026
Krasfarm's net profit under RAS for 2025 amounted to ₽198 million, increasing 2.9 times compared to ₽68 million in the previous year. Revenue increased by 14.8% to ₽3.02 billion against ₽2.63 billion a year earlier.
General information
Company nameKraspharma
Tags#moex_otc
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business addressKrasnoyarskiy kr., g. Krasnoyarsk, ul. 60 Let Oktyabrya, zd. 2
Mailing address660042, Krasnoyarskiy kr., g. Krasnoyarsk, ul. 60 Let Oktyabrya, zd. 2
Websitekraspharma.ru
Information disclosuree-disclosure.ru